Conserved gammaherpesvirus kinase and histone variant H2AX facilitate gammaherpesvirus latency in vivo

Virology

Volumn 405, Issue 1, 2010, Pages 50-61

  Tarakanova, Vera L ^a   Stanitsa, Eleni ^a   Leonardo, Steven M ^a   Bigley, Tarin M ^a   Gauld, Stephen B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

DNA damage response; Gammaherpesvirus; H2AX; Herpesvirus protein kinase; Latency

Indexed keywords

GAMMAHERPES VIRUS 68 PROTEIN; HISTONE H2AX; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REACTIVATION; GAMMAHERPESVIRINAE; MOUSE; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SPLEEN CELL; VIRUS REPLICATION;

HERPESVIRIDAE;

EID: 77955515217     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.05.027     Document Type: Article

References (59)

1. Allman D., Lindsley R.C., DeMuth W., Rudd K., Shinton S.A., Hardy R.R. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 2001, 167:6834-6840.
2. Asano S., Honda T., Goshima F., Nishiyama Y., Sugiura Y. US3 protein kinase of herpes simplex virus protects primary afferent neurons from virus-induced apoptosis in ICR mice. Neurosci. Lett. 2000, 294:105-108.
3. Bartek J., Lukas J., Bartkova J. DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'. Cell Cycle 2007, 6:2344-2347.
4. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Orntoft T., Lukas J., Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005, 434:864-870.
5. Barton E.S., Lutzke M.L., Rochford R., Virgin H.W. Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J. Virol. 2005, 79:14149-14160.
6. Bassing C.H., Chua K.F., Sekiguchi J., Suh H., Whitlow S.R., Fleming J.C., Monroe B.C., Ciccone D.N., Yan C., Vlasakova K., Livingston D.M., Ferguson D.O., Scully R., Alt F.W. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8173-8178.
7. Bassing C.H., Suh H., Ferguson D.O., Chua K.F., Manis J., Eckersdorff M., Gleason M., Bronson R., Lee C., Alt F.W. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 2003, 114:359-370.
8. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J., Redon C., Pilch D.R., Olaru A., Eckhaus M., Camerini-Otero R.D., Tessarollo L., Livak F., Manova K., Bonner W.M., Nussenzweig M.C., Nussenzweig A. Genomic instability in mice lacking histone H2AX. Science 2002, 296:922-927.
9. Chang P.C., Fitzgerald L.D., Van Geelen A., Izumiya Y., Ellison T.J., Wang D.H., Ann D.K., Luciw P.A., Kung H.J. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase. Cancer Res. 2009, 69:5681-5689.
10. Collins C.M., Boss J.M., Speck S.H. Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein. J. Virol. 2009, 83:6484-6493.
11. Efstathiou S., Ho Y.M., Hall S., Styles C.J., Scott S.D., Gompels U.A. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J. Gen. Virol. 1990, 71:1365-1372.
12. Flano E., Husain S.M., Sample J.T., Woodland D.L., Blackman M.A. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 2000, 165:1074-1081.
13. Flano E., Kim I.J., Woodland D.L., Blackman M.A. gamma-Herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J. Exp. Med. 2002, 196:1363-1372.
14. Flano E., Kim I.J., Moore J., Woodland D.L., Blackman M.A. Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J. Immunol. 2003, 170:3828-3834.
15. Gershburg E., Pagano J.S. Conserved herpesvirus protein kinases. Biochim. Biophys. Acta 2008, 1784:203-212.
16. Gershburg E., Raffa S., Torrisi M.R., Pagano J.S. Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus. J. Virol. 2007, 81:5407-5412.
17. Haque M., Wang V., Davis D.A., Zheng Z.M., Yarchoan R. Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster. J. Virol. 2006, 80:7037-7051.
18. Herskowitz J., Jacoby M.A., Speck S.H. The murine gammaherpesvirus 68M2 gene is required for efficient reactivation from latently infected B cells. J. Virol. 2005, 79:2261-2273.
19. Huertas D., Sendra R., Munoz P. Chromatin dynamics coupled to DNA repair. Epigenetics 2009, 4:31-42.
20. Hwang S., Wu T.T., Tong L.M., Kim K.S., Martinez-Guzman D., Colantonio A.D., Uittenbogaart C.H., Sun R. Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo. J. Virol. 2008, 82:12498-12509.
21. Hwang S., Kim K.S., Flano E., Wu T.T., Tong L.M., Park A.N., Song M.J., Sanchez D.J., O'Connell R.M., Cheng G., Sun R. Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe 2009, 5:166-178.
22. Jacoby M.A., Virgin H.W., Speck S.H. Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J. Virol. 2002, 76:1790-1801.
23. Knipe D.M., Cliffe A. Chromatin control of herpes simplex virus lytic and latent infection. Nat. Rev. Microbiol. 2008, 6:211-221.
24. Krosky P.M., Baek M.C., Coen D.M. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol. 2003, 77:905-914.
25. Li H., Ikuta K., Sixbey J.W., Tibbetts S.A. A replication-defective {gamma}-herpesvirus efficiently establishes long-term latency in macrophages but not B cells in vivo. J. Virol. 2008, 82(17):8500-8508.
26. Liang X., Collins C.M., Mendel J.B., Iwakoshi N.N., Speck S.H. Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog. 2009, 5:e1000677.
27. Lilley C.E., Carson C.T., Muotri A.R., Gage F.H., Weitzman M.D. DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5844-5849.
28. Lilley C.E., Schwartz R.A., Weitzman M.D. Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol. 2007, 15:119-126.
29. Lilley C.E., Chaurushiya M.S., Weitzman M.D. Chromatin at the intersection of viral infection and DNA damage. Biochim. Biophys. Acta 2009, 1799(3-4):319-327.
30. Martinez-Guzman D., Rickabaugh T., Wu T.T., Brown H., Cole S., Song M.J., Tong L., Sun R. Transcription program of murine gammaherpesvirus 68. J. Virol. 2003, 77:10488-10503.
31. Mezhir J.J., Advani S.J., Smith K.D., Darga T.E., Poon A.P., SCHMIDT H., Posner M.C., Roizman B., Weichselbaum R.R. Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses. Cancer Res. 2005, 65:9479-9484.
32. Milho R., Smith C.M., Marques S., Alenquer M., May J.S., Gillet L., Gaspar M., Efstathiou S., Simas J.P., Stevenson P.G. In vivo imaging of murid herpesvirus-4 infection. J. Gen. Virol. 2009, 90:21-32.
33. Moffat J.F., Zerboni L., Sommer M.H., Heineman T.C., Cohen J.I., Kaneshima H., Arvin A.M. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:11969-11974.
34. Moser J.M., Upton J.W., Allen R.D., Wilson C.B., Speck S.H. Role of B-cell proliferation in the establishment of gammaherpesvirus latency. J. Virol. 2005, 79:9480-9491.
35. Pandita T.K., Richardson C. Chromatin remodeling finds its place in the DNA double-strand break response. Nucleic Acids Res. 2009, 37:1363-1377.
36. Prichard M.N. Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir. Rev. Med. Virol. 2009, 19:215-229.
37. Rios-Doria J., Velkova A., Dapic V., Galan-Caridad J.M., Dapic V., Carvalho M.A., Melendez J., Monteiro A.N. Ectopic expression of histone H2AX mutants reveals a role for its post-translational modifications. Cancer Biol. Ther. 2009, 8:422-434.
38. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273:5858-5868.
39. Sangster M.Y., Topham D.J., D'Costa S., Cardin R.D., Marion T.N., Myers L.K., Doherty P.C. Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J. Immunol. 2000, 164:1820-1828.
40. Sato H., Pesnicak L., Cohen J.I. Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency. J. Virol. 2003, 77:11180-11185.
41. Siegel A.M., Herskowitz J.H., Speck S.H. The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. Plos Pathog. 2008, 4.
42. Siegel A.M., Rangaswamy U.S., Napier R.J., Speck S.H. Blimp-1 dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses. J. Virol. 2009, 84(2):674-685.
43. Stevenson P.G., Doherty P.C. Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J. Virol. 1999, 73:1075-1079.
44. Stevenson P.G., Efstathiou S. Immune mechanisms in murine gammaherpesvirus-68 infection. Viral Immunol. 2005, 18:445-456.
45. Sunil- Chandra N.P., Efstathiou S., Nash A.A. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 1992, 73:3275-3279.
46. Tarakanova V.L., Leung-Pineda V., Hwang S., Yang C.-W., Matatall K., Basson M., Sun R., Piwnica-Worms H., Sleckman B.P., Virgin H.W. Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 2007, 1:275-286.
47. Tibbetts S.A., Loh J., van B.V., McClellan J.S., Jacoby M.A., Kapadia S.B., Speck S.H., Virgin H.W. Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J. Virol. 2003, 77:7696-7701.
48. Upton J.W., Speck S.H. Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin. J. Virol. 2006, 80:11946-11959.
49. van Attikum H., Gasser S.M. Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol. 2009, 19:207-217.
50. Van Dyk L.F., Virgin H.W., Speck S.H. The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J. Virol. 2000, 74:7451-7461.
51. Van Dyk L.F., Virgin H.W., Speck S.H. Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes. J. Virol. 2003, 77:5118-5126.
52. Virgin H.W., Latreille P., Wamsley P., Hallsworth K., Weck K.E., Dal Canto A.J., Speck S.H. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 1997, 71:5894-5904.
53. Wang J.T., Doong S.L., Teng S.C., Lee C.P., Tsai C.H., Chen M.R. Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J. Virol. 2009, 83:1856-1869.
54. Weck K.E., Barkon M.L., Yoo L.I., Speck S.H., Virgin H.W. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J. Virol. 1996, 70:6775-6780.
55. Weck K.E., Kim S.S., Virgin H.W., Speck S.H. B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 1999, 73:4651-4661.
56. Weck K.E., Kim S.S., Virgin H.W., Speck S.H. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 1999, 73:3273-3283.
57. Willer D.O., Speck S.H. Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J. Virol. 2003, 77:8310-8321.
58. Wolf D.G., Courcelle C.T., Prichard M.N., Mocarski E.S. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1895-1900.
59. Yin B., Bassing C.H. The sticky business of histone H2AX in V(D)J recombination, maintenance of genomic stability, and suppression of lymphoma. Immunol. Res. 2008, 42:29-40.